| 摘要 |
The invention provides a method for the treatment of heterozygous familial hypercholesterolemia by administering the compound (R)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxy-hept-6-enoic acid (rosuvastatin ZD-4522) or a pharmaceutically acceptable salt thereof.
|
